Perceptive Advisors - LYRA THERAPEUTICS INC ownership

LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 38 filers reported holding LYRA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of LYRA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$49,882,067
-4.9%
12,757,5620.0%1.66%
+9.6%
Q2 2023$52,433,579
+185.2%
12,757,562
+39.5%
1.52%
+179.6%
Q1 2023$18,384,927
-36.0%
9,146,7300.0%0.54%
-32.6%
Q4 2022$28,720,732
-37.3%
9,146,7300.0%0.81%
-39.4%
Q3 2022$45,825,000
-11.3%
9,146,7300.0%1.33%
-17.9%
Q2 2022$51,679,000
+298.9%
9,146,730
+183.8%
1.62%
+522.7%
Q1 2022$12,955,000
-53.9%
3,222,560
-50.0%
0.26%
+19.8%
Q4 2021$28,100,000
-4.4%
6,445,120
+100.0%
0.22%
-49.2%
Q3 2021$29,403,000
-43.2%
3,222,560
-50.0%
0.43%
+27.1%
Q2 2021$51,754,000
+38.6%
6,445,120
+100.0%
0.34%
-28.8%
Q1 2021$37,349,000
+1.7%
3,222,560
-0.0%
0.47%
+19.8%
Q4 2020$36,737,000
+2.0%
3,222,5610.0%0.39%
-25.1%
Q3 2020$36,028,000
-1.4%
3,222,5610.0%0.53%
-11.1%
Q2 2020$36,543,0003,222,5610.59%
Other shareholders
LYRA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 2,780,261$10,870,8213.33%
Perceptive Advisors 12,757,562$49,882,0671.66%
Nantahala Capital Management 4,050,218$15,836,3521.35%
PURA VIDA INVESTMENTS, LLC 1,413,242$5,525,7761.04%
Ikarian Capital, LLC 1,254,384$4,904,6410.59%
Parkman Healthcare Partners LLC 625,056$2,443,9690.45%
VR Adviser, LLC 924,170$3,613,5050.38%
Soleus Capital Management, L.P. 592,417$2,316,3500.21%
ARMISTICE CAPITAL, LLC 1,550,000$6,060,5000.09%
Clearline Capital LP 119,128$465,7900.04%
View complete list of LYRA THERAPEUTICS INC shareholders